Reuters logo
BRIEF-Biospecifics Technologies reports Q3 eps of $0.37
November 10, 2017 / 1:28 PM / 14 days ago

BRIEF-Biospecifics Technologies reports Q3 eps of $0.37

Nov 10 (Reuters) - Biospecifics Technologies Corp:

* Biospecifics Technologies Corp reports Q3 2017 financial results

* Q3 revenue $6.5 million versus $6.9 million

* Q3 earnings per share $0.37

* As of september 30, 2017, co had cash & cash equivalents & investments of $61.3 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below